UNH Quantitative Stock Analysis

Validea's Growth Investor model, based on Martin Zweig's strategy, rates UnitedHealth Group (UNH) at 77%, falling below the 80% threshold for 'some interest.' While the large-cap growth stock passes several criteria including P/E ratio and current quarter earnings, it fails on key growth consistency metrics such as revenue growth in relation to EPS growth and earnings growth rate for the past several quarters, indicating fundamental areas that prevent stronger interest from this growth-focused strategy.

Analysis

UnitedHealth Group (UNH) scores a 77% on Validea's Growth Investor model, which is based on the Martin Zweig strategy, placing it just below the 80% threshold that indicates model interest. The analysis reveals a mixed fundamental picture for the large-cap health insurance firm. On the positive side, UNH passes several key criteria, including maintaining a reasonable P/E ratio, positive sales growth, strong current quarter earnings, and favorable insider transaction trends. It also demonstrates earnings persistence and solid long-term EPS growth. However, the model flags critical weaknesses that prevent a higher score, specifically pointing to a lack of consistent, accelerating growth. UNH fails on the metric comparing revenue growth to EPS growth, suggesting that bottom-line expansion may not be fully supported by top-line momentum. Furthermore, it fails on criteria for earnings growth over the past several quarters and for the current quarter's EPS growth relative to its historical rate, indicating a potential deceleration that is inconsistent with the core tenets of the Zweig growth-focused methodology.

Key Decisions for Investors

• Investors adhering to strict momentum or accelerating growth strategies, like the Zweig model, should note the 77% score and key failures in earnings acceleration as a signal for caution before initiating or adding to positions.
• For investors with a 'Growth at a Reasonable Price' (GARP) or long-term value focus, the passing grades on P/E ratio, sales growth, and earnings persistence may still present a case for holding the stock, despite the lack of near-term growth acceleration.
• Monitor UNH's upcoming quarterly reports to see if the flagged inconsistencies resolve, paying close attention to whether revenue growth begins to align more closely with EPS growth and if earnings growth re-accelerates relative to previous quarters.